According to Next Move Strategy Consulting, the global Minimally Invasive Surgical Systems Market, is projected to grow at a CAGR of 7.8% from 2024 to 2030, reaching USD 56.21 billion by 2030. This growth is fueled by the increasing prevalence of chronic diseases, a rapidly aging population, and technological advancements in surgical systems, including the integration of artificial intelligence (AI) and robotics.
Minimally invasive surgery (MIS) involves performing surgical procedures through small incisions using specialized instruments such as endoscopes, laparoscopy tools, and robotic systems. These techniques offer numerous benefits over traditional open surgeries, including reduced trauma, shorter recovery times, minimized scarring, and decreased postoperative pain. As a result, MIS has become a cornerstone in various medical specialties, including gynecology, orthopedics, cardiovascular surgery, and more.
Key Market Drivers
- Rising Prevalence of Chronic Diseases
The global surge in chronic diseases, such as cardiovascular diseases, cancer, and obesity, has significantly increased the demand for minimally invasive surgical interventions. According to the World Health Organization (WHO), non-communicable diseases (NCDs) account for 74% of global deaths annually, with cardiovascular diseases alone causing 17.9 million deaths per year. Minimally invasive surgical systems provide a safer and more effective alternative for treating these conditions, enabling healthcare professionals to perform complex procedures with reduced risks and complications.
- Aging Population
The growing elderly population is another major driver of market growth. As people age, they are more likely to require surgical interventions for age-related health conditions. Minimally invasive procedures are particularly favored among older patients due to their lower risk profiles and faster recovery times. The WHO reports that the global population aged 60 and above is expected to rise from 1.4 billion in 2020 to 2.1 billion by 2050, further boosting the demand for advanced surgical solutions.
- Technological Advancements
The integration of AI in surgical robotics is revolutionizing the Minimally Invasive Surgical Systems Market. AI-powered systems enhance surgical precision, provide real-time data analysis, and enable autonomous navigation, adaptive control, and real-time feedback. For instance, in September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute launched the Canady Robotic AI Surgical System, the world’s first AI robotic system capable of generating cold atmospheric plasma and a 3D bioelectric pulse electromagnetic field. Such innovations are paving the way for smarter, more efficient surgical tools and improved patient outcomes.
Market Challenges
Despite its promising growth, the market faces challenges, particularly the high initial costs associated with acquiring and implementing minimally invasive surgical systems. The expenses related to advanced robotic systems, training programs for healthcare professionals, and infrastructure adaptations pose significant financial barriers for healthcare institutions, especially those operating on constrained budgets.
Regional Insights
North America Dominates the Market
North America holds the largest share of the minimally invasive surgical systems market, driven by the high prevalence of chronic diseases, such as cancer and obesity, and the presence of leading market players. According to the American Cancer Society, 1.9 million new cancer cases were diagnosed in the U.S. in 2021, underscoring the need for advanced surgical solutions. Key players like Stryker Corporation, Abbott Laboratories, and Intuitive Surgical are investing heavily in research and development to maintain their market dominance. For example, in February 2022, Stryker launched the PROstep MICA SOLO Guide, a tool designed to simplify minimally invasive bunion procedures.
Europe Shows Steady Growth
Europe is expected to witness steady growth in the minimally invasive surgical systems market, fueled by the adoption of advanced technologies such as robot-assisted surgery. In February 2021, CMR Surgical introduced the Versius Surgical Robotic System in Germany, making robotic surgery more accessible and affordable. Additionally, initiatives like the surgical robotics program at Manchester University NHS Foundation Trust are driving the integration of robotic systems into healthcare practices across the continent.
Competitive Landscape
The global minimally invasive surgical systems market is highly competitive, with key players such as Medtronic plc, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, and Intuitive Surgical leading the way. These companies are focusing on strategic initiatives, including new product launches and partnerships, to strengthen their market positions.
- In December 2022, Abbott launched the Navitor Transcatheter Aortic Valve Implantation (TAVI) System, a minimally invasive device designed to treat aortic stenosis, a life-threatening heart valve disease.
- In October 2022, Medtronic plc received regulatory approvals for its Hugo robotic-assisted surgery (RAS) system, expanding access to minimally invasive surgery in Europe, North America, and Asia.
Market Segmentation
The minimally invasive surgical systems market is segmented by product, end user, and region:
By Product
- Surgical Robotic Systems
- Conventional Minimally Invasive Surgical Equipment
- Endoscopy
- Laparoscopy
- Operating Room (OR) Systems
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, Italy, Spain, etc.)
- Asia-Pacific (China, India, Japan, South Korea, etc.)
- Rest of the World (South Africa, Brazil, Saudi Arabia, etc.)
Future Outlook
The minimally invasive surgical systems market is poised for sustained growth, driven by the increasing demand for advanced medical solutions, the integration of AI and robotics, and the rising prevalence of chronic diseases and aging populations. As healthcare providers continue to prioritize patient safety, efficiency, and recovery, minimally invasive surgical systems will play an increasingly vital role in shaping the future of global healthcare.
